Adeno-Associated Virus Manufacturing Enhanced by Virica and Ginkgo Partnership to Lower Gene Therapy Costs
Key TakeawaysVirica Biotech and Ginkgo Bioworks have joined forces to enhance adeno-associated virus gene therapy production by combining Ginkgo’s advanced screening platform with...
Lower Back Pain Treatment Advances with New ICD-10 Code for Multifidus Muscle Dysfunction and ReActiv8 Therapy
Key TakeawaysThe U.S. CDC has introduced a new ICD-10-CM diagnostic code, M62.85, specifically for multifidus muscle dysfunction in the lumbar region, recognizing its...
Dry Eye Disease Treatment Advances with EU Approval of Vevizye® for Moderate to Severe Cases
Key TakeawaysNovaliq and Laboratoires Théa announced that Vevizye® has been approved by the European Commission for the treatment of moderate to severe dry...
Dry Eye Disease Treatment Advances with Reproxalap’s Resubmitted FDA Application
Key TakeawaysAldeyra Therapeutics has resubmitted its New Drug Application for reproxalap to the FDA, seeking approval for its use in treating the signs...
Breast Cancer Treatment Advances as Enhertu Receives Priority Review for HER2-Low and HER2-Ultralow Metastatic Patients
Key TakeawaysThe FDA has granted Priority Review to Enhertu for the treatment of HER2-low and HER2-ultralow metastatic breast cancer, based on positive results...
Scalp Psoriasis Treatment Advances with Sotyktu Showing Significant Efficacy in Clinical and Real-World Settings
Key TakeawaysIn the Phase 3b/4 PSORIATYK SCALP trial, Sotyktu demonstrated a significant improvement in moderate-to-severe scalp psoriasis, with 48.5% of patients achieving clear...
Diabetes and Weight-Loss Drugs Mounjaro and Zepbound No Longer in Shortage, FDA Reinforces Compounding Restrictions
Key TakeawaysThe FDA has officially declared the end of the shortage for Eli Lilly’s Mounjaro and Zepbound, signaling improved availability of these popular...
Mantle Cell Lymphoma Treatment Advances with FDA Priority Review for Calquence
Key TakeawaysThe FDA has granted Priority Review for AstraZeneca's Calquence, a promising new treatment for untreated mantle cell lymphoma, based on data showing...
Non-Small Cell Lung Cancer Treatment Advances with FDA Approval of Perioperative Opdivo Regimen
Key TakeawaysThe U.S. FDA has approved Opdivo in combination with chemotherapy for the perioperative treatment of resectable non-small cell lung cancer, marking a...
Healthcare Administration Solutions: Streamlining Operations and Enhancing Clinical Excellence
Key TakeawaysThe partnership between HealthAxis and COPE Health Solutions will deliver end-to-end healthcare administration solutions that streamline operations, reduce costs, and enhance clinical...
